Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity

Journal of Controlled Release

Volumn 104, Issue 3, 2005, Pages 489-496

  Memisoglu Bilensoy, Erem ^a   Vural, Imran ^a   Bochot, Amélie ^b   Renoir, Jack Michel ^b   Duchene, Dominique ^b   Hincal, A Atilla ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Amphiphilic cyclodextrin; Characterization; Cytotoxicity; Nanoparticle; Tamoxifen citrate

Indexed keywords

COMPLEXATION; ESTERS; INCLUSIONS; PARTICLE SIZE ANALYSIS; PRECIPITATION (CHEMICAL); TOXICITY;

INCLUSION COMPLEXES; NANOPRECIPITATION; NANOSPHERES; TAMOXIFEN CITRATE;

NANOSTRUCTURED MATERIALS;

AMPHOPHILE; BETA CYCLODEXTRIN; NANOCAPSULE; NANOPARTICLE; TAMOXIFEN CITRATE;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; HUMAN; HUMAN CELL; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SLOW RELEASE FORMULATION; ZETA POTENTIAL;

EID: 19444365656     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.03.006     Document Type: Article

References (23)

1. R.M. O'Reagan, and V.C. Jordan The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators Lancet Oncol. 3 2002 207 214
2. S.G. Pappas, and V.C. Jordan Chemoprevention of breast cancer: current and future prospects Cancer Metastasis Rev. 21 2002 311 321
3. T.J. Powles Anti-oestrogenic chemoprevention of breast cancer-the need to progress Eur. J. Cancer 39 2003 572 579
4. C. Peters-Engl, W. Frank, E. Danmayr, H.P. Friedl, S. Leodolter, and M. Medl Association between endometrial cancer and tamoxifen treatment of breast cancer Breast Cancer Treat. 54 1999 255 260
5. I. Cohen Endometrial pathologies associated with postmenopausal tamoxifen treatment Gynecol. Oncol. 94 2004 256 266
6. G.R. deLima, G. Facina, J.Y. Shida, M.B.C. Chein, P. Tanaka, R.C. Dardes, V.C. Jordan, and L.H. Gebrim Effects of low dose tamoxifen on normal breast tissue from premenopausal women Eur. J. Cancer 39 2003 891 898
7. J.S. Chawla, and M.M. Amiji Biodegradable poly(ε-caprolactone) nanoparticles for tumor targeted delivery of tamoxifen Int. J. Pharm. 249 2002 127 138
8. I. Brigger, P. Chaminade, V. Marsaud, M. Appel, M. Besnard, R. Gurny, M. Renoir, and P. Couvreur Tamoxifen encapsulation within polyethylene glycol-coated nanospheres Int. J. Pharm. 214 2001 37 42
9. D. Duchene, G. Ponchel, and D. Wouessidjewe Cyclodextrins in targeting. Applications to nanoparticles Adv. Drug Deliv. Rev. 36 1999 29 40
10. E. Memisoglu, A. Bochot, M. Şen, D. Charon, D. Duchene, and A.A. HIncal Amphiphilic β-cyclodextrins modified on the primary face: synthesis, characterization and evaluation of their potential as novel excipients in the preparation of nanocapsules J. Pharm. Sci. 91 5 2002 1214 1224
11. M. Skiba, D. Wouessidjewe, H. Fessi, J.P. Devissaguet, D. Duchene, F. Puisieux, Preparation et utilisation des nouveaux systemes colloidaux dispersibles a base de cyclodextrines, sous forme de nanospheres. French Patent, 92 07287, 1992.
12. M. Skiba, D. Wouessidjewe, H. Fessi, J.P. Devissaguet, D. Duchene, F. Puisieux. Preparation et utilisation des nouveaux systemes colloidaux dispersibles a base de cyclodextrines, sous forme de nanocapsules. French Patent, 92 07285, 1992.
13. A. Geze, S. Aous, I. Baussanne, J.L. Putaux, J. Defaye, and D. Wouessidjewe Influence of chemical structure of zamphiphilic β-cyclodextrins on their ability to form stable nanoparticles Int. J. Pharm. 242 2002 301 305
14. A.A. HIncal, E. Memisoglu-Bilensoy, A. Bochot, and D. Duchene β-Cyclodextrines amphiphiles: evaluation de nouveaux excipients pour la preparation de nanoparticules pour l'administration par voie parenterale ou topique Bull. Tech. Gattefossé 96 2 2003 35 48
15. A. Dubes, H. Parrot-Lopez, W. Abdelwahed, G. Degobert, H. Fessi, P. Shahgaldian, and A.W. Coleman Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins Eur. J. Pharm. Biopharm. 55 3 2003 279 282
16. E. Memisoglu, A. Bochot, M. Özalp, M. Şen, D. Duchene, and A.A. HIncal Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes Pharm. Res. 20 1 2003 117 125
17. E. Memisoglu, A. Bochot, M. Şen, D. Duchene, and A.A. HIncal Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins Int. J. Pharm. 251 2003 143 153
18. E. Memisoglu, I. Vural, D. Güç, L. Doǧan, and A.A. HIncal Evaluation of in vitro cytotoxicity of amphiphilic β-cyclodextrin nanospheres and nanocapsules on human fibroblasts and granulocytes Eur. J. Pharm. Sci. 17 Suppl. 1 2002 S81
19. H. Fessi, J.P. Devissaguet, C. Thies, Process for the preparation of dispersible colloidal systems of a substance in the form of nanospheres. US Patent, 5,118,529, 1988.
20. E. Memisoglu-Bilensoy, A. Bochot, D. Duchene, and A.A. HIncal Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles Proceedings of the 12th International Cyclodextrin Symposium, 16-19 May, Montpellier 2004
21. X.H. Yang, T.L. Sladek, X. Liu, B.R. Butler, C.J. Froelich, and A.D. Thor Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis Cancer Res. 61 2001 348 354
22. D. Duchene, D. Wouessidjewe, and G. Ponchel Cyclodextrins and carrier systems J. Contol Release 62 1999 263 268
23. D. Wouessidjewe, M. Skiba, F. Leroy-Lechat, E. Lemos-Senna, F. Puisieux, and D. Duchene A new concept in drug delivery based ≪ skirt-shaped cyclodextrin aggregates ≫ present state and future prospects STP Pharma. Sci. 6 1996 21 28